Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134128) titled 'Clinical study of Amitinofovir in antiviral treatment of Hepatitis B virus related HCC' on Oct. 11.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Zhuhai People's Hospital
Condition:
Chronic Hepatitis B?Hepatocellular carcinoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2024-06-15
Target Sample Size: Hepatitis B related HCC group(study group):100;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=240535
Disclaimer: Curated by HT Syndication....